Document:

Exhibit
4.5

 

Series
8 of Olden Lane Trust

 

Series
Supplement

 

Dated:
November 21, 2017

 

This
Series Supplement dated as of November 21, 2017 (the “Series Supplement”), executed by Olden Lane Securities LLC,
as Depositor, hereby creates Series 8 of Olden Lane Trust (the “Trust”). The Series shall be governed by the terms
of this Series Supplement and the Master Trust Agreement dated as of February 10, 2015 between Olden Lane Securities LLC, as Depositor
and Wilmington Trust, National Association, as the Trustee (the “Trust Agreement”).

 

Witnesseth
That:

 

WHEREAS
pursuant to the Trust Agreement one or more Series of Olden Lane Trust may be established, each of which Series is to be a unit
investment trust registered under the Investment Company Act of 1940, as amended, all as provided in the Trust Agreement; and

 

WHEREAS
the assets and specific terms of Series 8 of Olden Lane Trust shall be as set forth in this Series Supplement, the Master Services
Agreement and the related Series MSA Supplement.

 

NOW,
THEREFORE, the parties hereto, hereby agree:

 

PART
I

Master Trust Agreement

 

Subject
to the provisions of Part II and III hereof, all the provisions contained in the Trust Agreement are herein incorporated by reference
in their entirety and shall be deemed to be a part of this instrument as fully and to the same extent as though said provisions
had been set forth in full in this instrument. In the event of any inconsistency between the provisions of this Series Supplement
and the provisions of the Trust Agreement, the Series Supplement will prevail. All capitalized terms not otherwise defined herein
shall have the meaning ascribed in the Trust Agreement.

 

PART
II

Creation of Series 8 of Olden Lane Trust

 

1.           This
Series of beneficial interest in the Trust shall be known and is hereby established and designated as “Series 8 of Olden
Lane Trust” (the “Series 8 of Trust”).

 

2.           The
debts, liabilities, obligations and expenses incurred, contracted for or otherwise existing with respect to the Series 8 of Trust
shall be enforceable against the assets of the Series 8 of Trust only, and not against the assets of Olden Lane Trust generally
or the assets of any other Series of Olden Lane Trust. Further, none of the debts, liabilities, obligations and expenses incurred,
contracted for or otherwise existing with respect to the Series 8 of Trust shall be enforceable against the assets of any other
Series of Olden Lane Trust.

 

3.           The
validity and construction of this Series Supplement and all amendments hereto shall be governed by the laws of the State of Delaware,
and the rights of all parties hereto and the effect of every provision hereof shall be subject to and construed according to the
laws of the State of Delaware without regard to the conflicts of law provisions thereof; provided, however, that the Depositor
and the Unitholders intend that the provisions hereof shall control over any contrary or limiting statutory or common law of the
State of Delaware (other than the Act) and that, to the maximum extent permitted by applicable law, there shall not be applicable
to the Series 8 of Trust, the Depositor, the Trustee, the Unitholders or this Series Supplement any provision of the laws

 

    	 

     

    

 

(statutory
or common) of the State of Delaware (other than the Act) pertaining to trusts which relate to or regulate in a manner inconsistent
with the terms hereof: (a) the filing with any court or governmental body or agency of trustee accounts or schedules of trustee
fees and charges, (b) affirmative requirements to post bonds for trustees, officers, agents, or employees of a trust, (c) the
necessity for obtaining court or other governmental approval concerning the acquisition, holding or disposition of real or personal
property, (d) fees or other sums payable to trustees, officers, agents or employees of a trust, (e) the allocation of receipts
and expenditures to income or principal, (f) restrictions or limitations on the permissible nature, amount or concentration of
trust investments or requirements relating to the titling, storage or other manner of holding of trust assets, (g) the existence
of rights or interests (beneficial or otherwise) in trust assets, (h) the ability of beneficial owners or other persons to terminate
or dissolve a trust, or (i) the establishment of fiduciary or other standards or responsibilities or limitations on the acts or
powers of trustees or beneficial owners that are inconsistent with the limitations on liability or authorities and powers of the
Trustee or the Unitholders set forth or referenced in the Trust Agreement or this Series Supplement. Sections 3540, 3542 and 3561
of Title 12 of the Delaware Code shall not apply to the Series 8 of Trust.

 

PART
III

Special Terms and Conditions of Series 8 of Olden Lane Trust

 

The
Series 8 of Trust specifies the following special terms and conditions:

 

1.            The
Securities for the Series 8 of Trust listed in Part 1 of Schedule A hereto have been deposited with the Custodian. Listed in Part
2 of Schedule A are Contract Securities; the Depositor will cause the Securities represented by such Contract Securities to be
delivered to the Custodian as provided in the Master Services Agreement.

 

2.            The
aggregate number of Units for the Series 8 of Trust described in Section 2.03(a) of the Master Services Agreement is that number
of Units set forth under “Statement of Financial Condition—Number of Units” in the Prospectus for the Series
8 of Trust.

 

3.            The
undivided beneficial interest in and ownership of the Series 8 of Trust represented by each Unit thereof is a fractional amount,
the numerator of which is one and the denominator of which shall be the amount set forth under “Statement of Financial Condition—Number
of Units” in the Prospectus for the Series 8 of Trust.

 

4.            For
each Security, the Underlying Asset to Unit Ratio for the Series 8 of Trust shall be equal to the ratio of (i) the “Aggregate
Principal Amount” in respect of such Securities set forth under “Portfolio” in the Prospectus for Series 8 of
Trust to (ii) the number of Units for Series 8 of Trust set forth under “Statement of Financial Condition—Number of
Units” in the Prospectus for the Series 8 of Trust.

 

5.            The
term “Record Dates” shall mean the “Record Dates” set forth under “Essential Information”
in the Prospectus for the Series 8 of Trust.

 

6.            The
term “Distribution Dates” shall mean the “Distribution Dates” set forth under “Essential
Information” in the Prospectus for the Series 8 of Trust.

 

7.            The
term “Special Record Dates” shall mean the dates that may be declared by the Depositor in accordance with Section
24 of the Series MSA Supplement.

 

8.            The
term “Special Distribution Dates” shall mean the dates that may be declared by the Depositor in accordance
with Section 24 of the Series MSA Supplement.

 

9.           
There shall be no “Deferred Sales Charge” or “Deferred Sales Charge Payment Dates.”

 

10.          The
term “Business Day” shall be as defined in the Master Services Agreement.

 

    	-2- 

     

    

 

11.          The
term “Mandatory Termination Date” shall mean the “Termination Date” set forth under “Essential
Information” in the Prospectus for the Series 8 of Trust.

 

12.          The
Series 8 of Trust shall elect to be a Regulated Investment Company and, if required, the Depositor shall, on behalf of the Series
8 of Trust, make or cause to be made such filings necessary to effect such an election.

 

13.          The
Depositor’s, Evaluator’s and Supervisor’s annual compensation shall be the amount set forth under “Fee
Table” in the Prospectus for the Series 8 of Trust.

 

14.          The
aggregate of the Custodian’s, the Transfer Agent’s and the Administrator’s annual compensation shall be the
amount set forth under “Fee Table” in the Prospectus for the Series 8 of Trust, with an aggregate minimum of $10,000
per annum.

 

15.          The
term “Initial Date of Deposit” for the Series 8 of Trust shall be the date of this Series Supplement.

 

16.          The
terms “Organization Expense Period” for the Series 8 of Trust shall mean the period ending on the earlier of
(i) the expiration of the initial offering period set forth in the Prospectus or (ii) the 180th day after the Initial
Deposit Date.

 

17.          The
“Creation and Development Fee” shall be the amount set forth under “Fee Table” in the Prospectus
for the Series 8 of Trust.

 

18.          Section
6.04 of the Master Services Agreement (“Rollover of Units”) shall not apply to the Series 8 of Trust.

 

19.          The
Depositor may direct the dissolution of the Series 8 of Trust in the event a Trust Series Evaluation made after the end of the
Initial Offering Period is less than 40% of the total value of Securities and Derivative Transactions deposited in such Series
8 of Trust during the Initial Offering Period.

 

20.          The
Depositor may direct the dissolution of the Series 8 of Trust if due to (i) any action taken by a governmental body, or brought
in court, or (y) a change in law (including tax law) or in the application or official interpretation of any law), there is or
there is a substantial likelihood that the Series 8 of Trust will be prohibited in any material way from pursuing its principal
investment strategy in the same manner and economic terms as on the inception date.

 

21.          The
Series 8 of Trust is not a Derivatives Trust Series.

 

This
Series Supplement shall be deemed effective when executed and delivered by the Depositor, on behalf of the Trust, to the Trustee.

 

    	-3- 

     

    

 

In
Witness Whereof, the undersigned have caused this Series Supplement
to be executed; all as of the day, month and year first above written.

 

	 	Series
                           8 of Olden Lane Trust,

                           a
                           Delaware Statutory Trust

	 	 

	 	By:	Olden
                           Lane Securities LLC,

                           as
                           Depositor

	 	 	 

	 	By:	/s/ Michel
    Serieyssol
	 	 	Michel Serieyssol

        CEO

  

    	-4- 

     

    

 

Schedule
A to Series Supplement

 

Securities
Initially Deposited

 

in

 

Series
8 of Olden Lane Trust

 

Part
1

 

Securities
Delivered to the Custodian on The initial Date of Deposit

 

Part
2

 

Contract
Securities

 

Incorporated
herein by this reference and made a part hereof is the “Trust Portfolio—Portfolio Composition” in schedule as
set forth in the Prospectus for Series 8 of Trust.

 

    	-5-Exhibit 10.41

 

RESDEVCO
LTD.

 

 

September
6, 2017

 

To
whom it may concern,

 

Resdevco,
the developer and owner of the IP of LO2A eye drops, has granted Wize Pharma Ltd. the sole rights to commercialize LO2A in
China.

 

/s/ Prof S. Dikstein

Prof
S Dikstein,

CEO and Founder

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

P.O.B.
3338, Jerusalem, Israel

Tel.
and Fax: 972-2-6524734

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00277-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00277-of-00352.parquet"}]]